Prevention of Renal Failure by Nitric Oxide in Prolonged Cardiopulmonary Bypass.

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 217 participants.

Also called NCT01802619

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 1/2
Enrolled
  • 217 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01802619
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01802619. Randomized; double masking; primary purpose prevention. Start 2013-08 (actual); primary completion 2015-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prevention of Renal Failure by Nitric Oxide in Prolonged Cardiopulmonary Bypass.
Condition
Heart Valve Diseases
Condition
Heart; Complications, Valve, Prosthesis
Condition
Cardiac Valve Replacement Complication
Intervention (Other)
inhaled nitric oxide
Intervention (Other)
inhaled Nitrogen
Lead sponsor
Xijing Hospital (class: other)

Record details

Record id
cardio:ct-nct01802619
Content hash
20cb812f56b7f368e49aacaec9e25501fde23098f3ff3459bf03b69f1db5a89d